| Dr Genevieve Lama, MD | |
|
2050 Saw Mill River Rd Ste 1, Yorktown Heights, NY 10598-4144 | |
| (914) 962-5533 | |
| (646) 317-1276 |
| Full Name | Dr Genevieve Lama |
|---|---|
| Gender | Female |
| Speciality | Endocrinology |
| Experience | 27 Years |
| Location | 2050 Saw Mill River Rd Ste 1, Yorktown Heights, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558348904 | NPI | - | NPPES |
| 02526814 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | 213126 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hudson Valley Hospital Center | Cortlandt manor, NY | Hospital |
| Putnam Hospital Center | Carmel, NY | Hospital |
| Vassar Brothers Medical Center | Poughkeepsie, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Westchester Medical Practice Pc | 9335238732 | 147 |
News Archive
Acuity, Incorporated, a fabless provider of stable high-performance MEMS pressure sensors, is now shipping the AC3050-010 very stable low pressure sensor die with a 10mbar full-scale rating. Expanding the low-pressure end of Acuity's piezoresistive pressure sensor product offerings to 10 mbar full-scale, the AC3050-010 complements the existing AC3030 series 20 to 100 mbar full-scale MEMS pressure sensor family. The AC3050-010 is targeted at low-pressure instrumentation in industrial measurement, medical and HVAC applications.
An efficient, high-volume technique for testing potential drug treatments for Alzheimer's disease uncovered an organic compound that restored motor function and longevity to fruit flies with the disease, according to new research that could help put the search for an effective Alzheimer's drug on a faster track.
Australia-US biotechnology company, Novogen Ltd., an oncology and degenerative diseases drug development company, today announced the results of its General Meeting of Shareholders, which was held on August 12 in Sydney, Australia.
REGENERX BIOPHARMACEUTICALS, INC. announced today that it has completed and analyzed the safety data from its double-blind, placebo controlled Phase I clinical trial evaluating the systemic administration of RGN-352. The trial included testing of a single escalating intravenous dose of the drug candidate on forty healthy volunteers in Phase IA and, subsequently, over a fourteen-day treatment period on forty volunteers in Phase IB.
› Verified 8 days ago
| Entity Name | The Westchester Medical Practice Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225222953 PECOS PAC ID: 9335238732 Enrollment ID: O20080502000160 |
News Archive
Acuity, Incorporated, a fabless provider of stable high-performance MEMS pressure sensors, is now shipping the AC3050-010 very stable low pressure sensor die with a 10mbar full-scale rating. Expanding the low-pressure end of Acuity's piezoresistive pressure sensor product offerings to 10 mbar full-scale, the AC3050-010 complements the existing AC3030 series 20 to 100 mbar full-scale MEMS pressure sensor family. The AC3050-010 is targeted at low-pressure instrumentation in industrial measurement, medical and HVAC applications.
An efficient, high-volume technique for testing potential drug treatments for Alzheimer's disease uncovered an organic compound that restored motor function and longevity to fruit flies with the disease, according to new research that could help put the search for an effective Alzheimer's drug on a faster track.
Australia-US biotechnology company, Novogen Ltd., an oncology and degenerative diseases drug development company, today announced the results of its General Meeting of Shareholders, which was held on August 12 in Sydney, Australia.
REGENERX BIOPHARMACEUTICALS, INC. announced today that it has completed and analyzed the safety data from its double-blind, placebo controlled Phase I clinical trial evaluating the systemic administration of RGN-352. The trial included testing of a single escalating intravenous dose of the drug candidate on forty healthy volunteers in Phase IA and, subsequently, over a fourteen-day treatment period on forty volunteers in Phase IB.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Genevieve Lama, MD 111 Clocktower Commons, Brewster, NY 10509 Ph: (845) 279-5187 | Dr Genevieve Lama, MD 2050 Saw Mill River Rd Ste 1, Yorktown Heights, NY 10598-4144 Ph: (914) 962-5533 |
News Archive
Acuity, Incorporated, a fabless provider of stable high-performance MEMS pressure sensors, is now shipping the AC3050-010 very stable low pressure sensor die with a 10mbar full-scale rating. Expanding the low-pressure end of Acuity's piezoresistive pressure sensor product offerings to 10 mbar full-scale, the AC3050-010 complements the existing AC3030 series 20 to 100 mbar full-scale MEMS pressure sensor family. The AC3050-010 is targeted at low-pressure instrumentation in industrial measurement, medical and HVAC applications.
An efficient, high-volume technique for testing potential drug treatments for Alzheimer's disease uncovered an organic compound that restored motor function and longevity to fruit flies with the disease, according to new research that could help put the search for an effective Alzheimer's drug on a faster track.
Australia-US biotechnology company, Novogen Ltd., an oncology and degenerative diseases drug development company, today announced the results of its General Meeting of Shareholders, which was held on August 12 in Sydney, Australia.
REGENERX BIOPHARMACEUTICALS, INC. announced today that it has completed and analyzed the safety data from its double-blind, placebo controlled Phase I clinical trial evaluating the systemic administration of RGN-352. The trial included testing of a single escalating intravenous dose of the drug candidate on forty healthy volunteers in Phase IA and, subsequently, over a fourteen-day treatment period on forty volunteers in Phase IB.
› Verified 8 days ago
Dr. Jack Leon Brenner, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1974 Maple Hill Street, Suite 6, Yorktown Heights, NY 10598 Phone: 914-962-5596 Fax: 914-962-5919 | |
Dr. Marcus Chenchi Lien, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2649 Strang Blvd Ste 304, Yorktown Heights, NY 10598 Phone: 914-739-0087 Fax: 914-737-1714 | |
Jimmy L Koo, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 48 Route 6 Ste 102, Care Mount Medcical Pc, Yorktown Heights, NY 10598 Phone: 914-248-5556 Fax: 914-248-4091 | |
Dr. Peter Mercurio, M.D. Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 1888 Commerce St, Yorktown Heights, NY 10598 Phone: 914-962-4000 Fax: 914-962-0280 | |
Dr. Madhavi Reddy Kancharla, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 3379 Crompond Rd, Yorktown Heights, NY 10598 Phone: 914-849-7060 Fax: 914-848-7062 | |
Daniela Spitzer, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2050 Saw Mill River Rd, Suite 1, Yorktown Heights, NY 10598 Phone: 914-962-5533 Fax: 914-962-5532 | |
Jeffrey Ambinder, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2649 Strang Blvd, Suite 208, Yorktown Heights, NY 10598 Phone: 914-245-6000 Fax: 914-245-1675 |